Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Investigating Breast Tissue Composition as a Risk Factor for Lymphedema Development Following Breast Cancer Treatment

EF 2024-25

Résumé
Background: Lymphedema is a common side effect of surgery and radiation therapy that will develop in about 20% of breast cancer survivors. Breast cancer-related lymphedema occurs when cancer treatment causes damage to the lymphatic system leading to an overaccumulation of lymphatic fluid in the breast or arm. This can cause pain and loss of mobility in patients. Published evidence by our group demonstrates that the type of breast tissue a person has may influence their risk of developing lymphedema. Fatty breast tissue is associated with an increased occurrence and severity of lymphedema. However, it is unclear what biological components of the breast tissue contribute to this risk. Purpose: The purpose of this study is to uncover the biological differences between fatty and non-fatty breast tissue types that could explain the difference in lymphedema risk. We hypothesize that fatty breast tissue may have fewer lymphatic cells and lower activity of lymphatic cells compared to non-fatty tissue.Methods: Single-cell RNA sequencing will be performed on fatty and non-fatty breast tissues to uncover differences in their composition including the types, numbers, and activities of the cells. From this information, targeted genetic experiments will be done to reveal the function of specific gene activities that are different between fatty and non-fatty breast tissue types. Significance: This research will lead to improved knowledge on the tissue factors that influence a patient risk of developing lymphedema and potentially lead to future preventive therapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529838
Name
Ma Mandi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Breast Tissue Composition as a Risk Factor for Lymphedema Development Following Breast Cancer Treatment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker; Breast Cancer; Lymphedema; Mammary Adiposity; Molecular Biology; Normal Tissue Toxicity; Radiotherapy; Risk Factor; Side Effects; Single-Cell Transcriptomics
Abstract
Background: Lymphedema is a common side effect of surgery and radiation therapy that will develop in about 20% of breast cancer survivors. Breast cancer-related lymphedema occurs when cancer treatment causes damage to the lymphatic system leading to an overaccumulation of lymphatic fluid in the breast or arm. This can cause pain and loss of mobility in patients. Published evidence by our group demonstrates that the type of breast tissue a person has may influence their risk of developing lymphedema. Fatty breast tissue is associated with an increased occurrence and severity of lymphedema. However, it is unclear what biological components of the breast tissue contribute to this risk. Purpose: The purpose of this study is to uncover the biological differences between fatty and non-fatty breast tissue types that could explain the difference in lymphedema risk. We hypothesize that fatty breast tissue may have fewer lymphatic cells and lower activity of lymphatic cells compared to non-fatty tissue.Methods: Single-cell RNA sequencing will be performed on fatty and non-fatty breast tissues to uncover differences in their composition including the types, numbers, and activities of the cells. From this information, targeted genetic experiments will be done to reveal the function of specific gene activities that are different between fatty and non-fatty breast tissue types. Significance: This research will lead to improved knowledge on the tissue factors that influence a patient risk of developing lymphedema and potentially lead to future preventive therapies.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ma, Mandi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~